Development of Virus-Like Particles (VLPs) for Hepatitis C Virus genotype 4: a novel approach for vaccine development in Egypt

Development of Virus-Like Particles (VLPs) for Hepatitis C Virus genotype 4: a novel approach for vaccine development in Egypt

Abstract Background Egypt has the highest global prevalence of Hepatitis C Virus (HCV) infection, particularly of genotype 4. The development of a prophylactic vaccine remains crucial for HCV eradication, yet no such vaccine currently exists due to the vaccine development challenges. The ability of...

Full description

Saved in:
Bibliographic Details
Main Authors: Ahmed A. Ali, Rasha A. M. Azouz, Nahla A. Hussein, Reem El-Shenawy, Naiera M. Helmy, Yasmine S. El-Abd, Ashraf A. Tabll
Format: Article
Language:English
Published: BMC 2025-01-01
Series:BMC Biotechnology
Subjects:
Hepatitis C Virus (HCV)
Virus-Like Particles (VLPs)
Genotype 4
Structural proteins
Vaccine
Lentivectors
Online Access:https://doi.org/10.1186/s12896-024-00935-5
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12896-024-00935-5

Similar Items